Compare Epidural vs. Lumbar Plexus Analgesia After Hip Arthroplasty

Arthropathy of Hip Clinical Trial

Official title:

Compare Effectiveness of Epidural vs. Lumbar Plexus Blocks in Total Hip Arthroplasty (THA) Patients Using Multimodal Pain Control

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02493621
• Other study ID #: Pro00040998
• Status: Completed
• Start date: December 2014
• Est. completion date: July 2015

Study information

• Verified date: June 2018
• Source: Medical University of South Carolina
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this retrospective chart review is to evaluate if the implementation of lumbar plexus block placement for postoperative pain have improved conditions in the postoperative period for patients undergoing total hip arthroplasty when compared to the placement of epidurals for postoperative pain management.

Description:

Primary outcome: 48 hour opiate consumption in patients following THA. ' Secondary outcome: Time to first ambulation, assistance needed with ambulation, opiate and regional related side effects, time to discharge orders.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 116
• Est. completion date: July 2015
• Est. primary completion date: June 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years and older

• Diagnosis of:

1. Primary THA, (identified by CPT code 27130)

2. Either a) Epidural (CPT code 62319) or b) Lumbar plexus peripheral nerve block (CPT 62311 or 64449)

• Perioperative multimodal medication

• Hospitalized from July 1, 2012 to December 17, 2014.

Exclusion Criteria:

• THA Revision

• ICU admission postoperatively

• History of dementia

Related Conditions & MeSH terms

• Arthropathy of Hip
• Joint Diseases

Locations

Country	Name	City	State
United States	Medical University of South Carolina	Charleston	South Carolina

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of South Carolina

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Opiate Consumption	Cumulative opiate consumption in intravenous (IV) morphine mg equivalents (MME)	48 hours postoperative
Secondary	Time of First Ambulation	Time of first ambulation relative to anesthesia end time (hours)	48 hours